The reduction of ACE2 protein expression and its mislocalization outside the plasma membrane is even more visible in primary well-differentiated bronchial epithelia obtained from CF patients carrying the F508del or class I mutations in CFTR (Fig. 5). Here, ACE2 is linked to cystic fibrosis.